World's Best Scientists 2026 revealed!
Award Badge
Medicine
UK
2026

D-Index & Metrics

Best Scientists

D-Index
164
Citations
130837
World Ranking
1063
National Ranking
106

Medicine

D-Index
165
Citations
134961
World Ranking
617
National Ranking
75

Jack Cuzick publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jack Cuzick sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 950 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jack Cuzick D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jack Cuzick sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 165 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in United Kingdom Leader Award
  • 2025 - Research.com Medicine in United Kingdom Leader Award
  • 2023 - Research.com Medicine in United Kingdom Leader Award
  • 2016 - Fellow of the Royal Society, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Jack Cuzick is affiliated with Queen Mary University of London in the United Kingdom. Their research spans multiple areas within medicine and the biomedical sciences, with a primary focus on oncology and cancer-related fields.

The scientist's main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology. More specifically, their subfields of specialization cover Oncology, Epidemiology, Cancer Research, Genetics, and Pulmonary and Respiratory Medicine.

Their research topics address a range of cancer-related themes such as:

  • Global Cancer Incidence and Screening
  • Cervical Cancer and HPV Research
  • Cancer Risks and Factors
  • Breast Cancer Treatment Studies
  • BRCA gene mutations in cancer
  • Genital Health and Disease
  • Estrogen and related hormone effects

Jack Cuzick has contributed to scientific literature published in several prominent venues, including:

  • Cancer Research
  • British Journal of Cancer
  • International Journal of Cancer
  • Gynecologic Oncology
  • The Lancet

Their frequently collaborating co-authors include:

  • Adam R. Brentnall
  • Ivana Šestak
  • Anthony Howell
  • Mitch Dowsett
  • D. Gareth Evans

Among notable recent papers authored or co-authored by Jack Cuzick are:

  • Key steps for effective breast cancer prevention, 2020, Nature reviews. Cancer
  • Personalized early detection and prevention of breast cancer: ENVISION consensus statement, 2020, Nature Reviews Clinical Oncology
  • Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial, 2020, The Lancet
  • Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13,864 women in seven randomised trials, 2021, The Lancet Oncology
  • Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC), 2020, British Journal of Cancer

The scientist has been recognized as a Fellow of the Royal Society in the United Kingdom since 2016. They are also a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

    E. E. Calle;C. W. Heath;R. J. Coates;J. M. Liff

  • Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

    C Focan;SM Steinberg;M Blichert-Toft;JF Forbes

  • Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

    M Baum;A U Budzar;J Cuzick;J Forbes

  • Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

    Anthony Howell

  • Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

    Mitch Dowsett;Torsten O. Nielsen;Roger A’Hern;John Bartlett

  • Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

    Wendy S. Atkin;Rob Edwards;Ines Kralj-Hans;Kate Wooldrage

  • A wilcoxon-type test for trend

    Jack Cuzick

  • Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies

    E. E. Calle;C. W. Heath;H. L. Miracle-McMahill;R. J. Coates

  • A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

    Elmar A. Joura;Anna R. Giuliano;Ole-Erik Iversen;Celine Bouchard

  • Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.

    Jack Cuzick;Ivana Sestak;Michael Baum;Aman U Buzdar

  • Overview of the European and North American studies on HPV testing in primary cervical cancer screening.

    Jack Cuzick;Christine Clavel;Karl Ulrich Petry;Chris J L M Meijer

  • Long-term risk of colorectal cancer after excision of rectosigmoid adenomas

    Wendy S. Atkin;Basil C. Morson;Jack Cuzick

  • Multivariate generalizations of the proportional hazards model

    D. Clayton;J. Cuzick

  • A breast cancer prediction model incorporating familial and personal risk factors.

    Jonathan Tyrer;Stephen W. Duffy;Jack Cuzick

  • Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses

    M Baum;A Buzdar;J Cuzick;J Forbes

  • Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists' Collaborative Group.

    IC Henderson;H Mouridsen;O Abe;M Abeloff

  • Overview of the main outcomes in breast-cancer prevention trials.

    J Cuzick;T Powles;U Veronesi;J Forbes

  • Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

    Guglielmo Ronco;Paolo Giorgi-Rossi;Francesca Carozzi;Massimo Confortini

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

Frequent Co-Authors

Anthony Howell
Anthony Howell University of Manchester
John F. Forbes
John F. Forbes University of Limerick
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
Daniel M. Berney
Daniel M. Berney Barts Health NHS Trust
Peter Sasieni
Peter Sasieni King's College London
Henrik Møller
Henrik Møller King's College London
Peter T. Scardino
Peter T. Scardino Memorial Sloan Kettering Cancer Center
Christopher S. Foster
Christopher S. Foster University of Liverpool
D. Gareth Evans
D. Gareth Evans University of Manchester
Cosette M. Wheeler
Cosette M. Wheeler University of New Mexico

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to several supportive fields and degree pathways, many of which can be accessed online. For those aiming to enter healthcare leadership, pursuing one of the cheapest mha programs is a cost-effective way to gain advanced management skills.

Nursing professionals looking to further their qualifications and clinical expertise might consider msn to dnp programs online. These programs are designed to help nurses transition into top-tier practice or academic roles.

Similarly, pharmacy is a fast-growing field and online education can make it more accessible. Interested students should review accredited online pharmacy programs to gain pharmaceutical expertise and open new career opportunities.

Finally, for those more interested in the digital and administrative side of healthcare, earning an online bachelor's in health information management provides essential skills for managing health data and technology within medical organizations.

These alternative degree pathways can supplement a medical education or serve as standalone routes into rewarding healthcare careers.

Best Scientists Citing Jack Cuzick

Trending Scientists

Recently Published Articles